1.河北中医学院研究生院,河北省石家庄市桥西区新石南路326号,050200
2.河北省中医院
3.河北省血液中心
4.河北省承德市中医院
hblxh2002@163.com
收稿:2022-11-11,
修回:2023-02-20,
纸质出版:2023-05-02
移动端阅览
李睿嘉,王永敏,李静等.银翘升板方辅助治疗风热伤络型原发免疫性血小板减少症35例随机对照研究[J].中医杂志,2023,64(09):924-929.
LI Ruijia,WANG Yongmin,LI Jing,et al.Yinqiao Shengban Formula (银翘升板方) Adjuvant Therapy for Primary Immune Thrombocytopenia of 35 Cases:a Randomized Controlled Trial[J].Journal of Traditional Chinese Medicine,2023,64(09):924-929.
李睿嘉,王永敏,李静等.银翘升板方辅助治疗风热伤络型原发免疫性血小板减少症35例随机对照研究[J].中医杂志,2023,64(09):924-929. DOI: 10.13288/j.11-2166/r.2023.09.011.
LI Ruijia,WANG Yongmin,LI Jing,et al.Yinqiao Shengban Formula (银翘升板方) Adjuvant Therapy for Primary Immune Thrombocytopenia of 35 Cases:a Randomized Controlled Trial[J].Journal of Traditional Chinese Medicine,2023,64(09):924-929. DOI: 10.13288/j.11-2166/r.2023.09.011.
目的
2
观察银翘升板方辅助治疗成人原发免疫性血小板减少症(ITP)风热伤络型的临床疗效。
方法
2
将74例ITP风热伤络型患者随机分为对照组和治疗组各37例,对照组给予泼尼松龙片1 mg/(kg·d)口服,或等效剂量的其他激素如甲泼尼龙片0.8 mg/(kg·d)口服,病情稳定后逐渐减量;治疗组在对照组基础上给予银翘升板方口服,每日1剂。两组均治疗8周后判定临床疗效及中医证候疗效。治疗前后比较两组患者血小板计数、出血症状评分、血栓弹力图关键参数[包括反应时间(R)、凝血时间(K)、最大振幅(MA)、综合凝血指数(CI)]。
结果
2
研究过程中对照组脱落4例,治疗组脱落2例,最终纳入本研究的患者为68例,其中治疗组35例,对照组33例。治疗组临床疗效总有效率为71.43%,中医证候疗效总有效率为74.29%,对照组分别为45.45%、30.30%,治疗组临床疗效和中医证候疗效均显著高于对照组(
P
<0.05或
P
<0.01)。与本组治疗前比较,两组患者治疗后血小板计数均升高、出血症状评分均降低,且治疗后治疗组患者血小板计数高于对照组、出血症状评分低于对照组(
P
<0.05或
P
<0.01)。两组患者血栓弹力图结果比较,MA、R、K值治疗前后差异均无统计学意义(
P
>0.05);两组患者治疗后CI值均较本组治疗前升高(
P
<0.05)。
结论
2
银翘升板方辅助治疗风热伤络型ITP临床疗效及中医证候疗效均优于单纯使用糖皮质激素药,可提升患者血小板计数,改善出血情况和低凝状态。
Objective
2
To explore the clinical effect of
Yinqiao Shengban Formula
(银翘升板方, YSF) adjuvant therapy for adult primary immune thrombocytopenia (ITP) with wind-heat damaging collaterals syndrome.
Method
2
Seventy-four ITP patients with wind-heat damaging collaterals syndrome were randomly divided into control group and treatment group, with 37 patients in each group. Both groups were treated with 0.8 mg/(kg·d) of oral prednisone tablet, or other hormones at an equivalent dose such as 0.8 mg/(kg·d) of oral methylprednisolone tablets, with reduced dosage as the condition gradually becomes stable; the treatment group additionally received YSF, one dose daily. After treatment of eight weeks, the clinical curative effect and effect regarding traditional Chinese medicine (TCM) symptoms were judged. The platelet count, bleeding score, and key parameters of thromboelastography including reaction time (R), coagulation time (K), maximum amplitude (MA) and coagulation index (CI) were compared between the two groups.
Results
2
Four cases in the control group and two cases in the control group dropped out during the study. Finally, 68 cases were included involving 35 cases in the treatment gorup and 33 cases in the control group. The total clinical effective rate and the effect regarding TCM symptoms of the treatment group was 71.43% and 74.29%, respectively, significantly higher than 45.45% and 30.30% of the control group(
P
<0.05 or
P
<0.01). The improvement degree of TCM clinical efficacy and syndrome in the treatment group was much better than that in the control group (
P
<0.01).After treatment, the platelet count increased,while the bleeding score significantly decreased in both groups, and more changes were found in treatment group (
P
<0.05 or
P
<0.01). Thromboelastography showed no statistical significant difference in MA, R and K values before and after treatment (
P
>0.05); the CI value significantly decreased after treatment in both groups (
P
<0.05).
Conclusion
2
On the basis of modern medical treatment, the application of YSF in adjuvant to glucocorticoid has better effect than glucocorticoid alone in the treatment of ITP with wind-heat damaging collaterals, which can improve the platelet count of patients, improve the bleeding and hypocoagulable condition.
KOHLI R , CHATURVEDI S . Epidemiology and clinical manifestations of immune thrombocytopenia [J]. Hamostaseologie , 2019 , 39 ( 3 ): 238 - 249 .
中华医学会血液学分会血栓与止血学组 . 成人原发免疫性血小板减少症诊断与治疗中国指南(2020年版) [J]. 中华血液学杂志 , 2020 , 41 ( 8 ): 617 - 623 .
刘锋 , 麻柔 . 第七届全国中西医结合血液病学术会议纪要 [J]. 中国中西医结合杂志 , 2005 , 25 ( 3 ): 288 .
国家中医药管理局 . 中医病证诊断疗效标准 [M]. 南京 : 南京大学出版社 , 1994 : 18 - 19 .
郑筱庾 . 中药新药临床研究指导原则(试行) [M]. 北京 : 中国医药科技出版社 , 2002 : 180 - 184 .
李昕雨 , 何杨 , 阮长耿 . 原发免疫性血小板减少症的治疗进展 [J]. 中国实验血液学杂志 , 2021 , 29 ( 3 ): 983 - 987 .
SANDAL R , MISHRA K , JANDIAL A , et al . Update on diagnosis and treatment of immune thrombocytopenia [J]. Expert Rev Clin Pharmacol , 2021 , 14 ( 5 ): 553 - 568 .
王瑞平 . 随机对照临床试验设计中的样本量估算方法 [J]. 上海医药 , 2023 , 44 ( 01 ): 48 - 52 .
MOULIS G , PALMARO A , MONTASTRUC JL , et al . Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France [J]. Blood , 2014 , 124 ( 22 ): 3308 - 3315 .
吴瑭 . 温病条辨 [M]. 北京 : 人民卫生出版社 , 2005 : 8 .
马冬梅 , 陶庆春 , 蒋东葵 , 等 . 四种清热解毒类中草药对广泛耐药鲍曼不动杆菌的体外抑菌比较 [J]. 环球中医药 , 2021 , 14 ( 7 ): 1192 - 1196 .
薛琴 . 黄芩等6味中药对多重耐药鲍曼不动杆菌的体外抑菌活性的实验研究 [J]. 抗感染药学 , 2021 , 18 ( 2 ): 159 - 162 .
AMINI SN , PORCELIJN L , SOBELS A , et al . Anti-glycoprotein antibodies and sequestration pattern of indium-labeled platelets in immune thrombocytopenia [J]. Blood Adv , 2022 , 6 ( 6 ): 1797 - 1803 .
SWINKELS M , RIJKERS M , VOORBERG J , et al . Emerging concepts in immune thrombocytopenia [J]. Front Immunol , 2018 , 9 ( 1 ): 880 - 894 .
董莉莳 , 何荣霞 , 路丽 , 等 . 血栓弹力图及血小板相关参数在妊娠期血小板减少症患者中的变化特点 [J]. 疑难病杂志 , 2022 , 21 ( 5 ): 507 - 511 .
陈小欢 , 王前 , 吴东升 , 等 . 血栓弹力图在评估成人原发免疫性血小板减少症患者出血风险中的临床应用价值 [J]. 吉林医学 , 2021 , 42 ( 9 ): 2217 - 2219 .
翁美玲 , 汪敏 , 顾晔 , 等 . 血清TPO及HPA水平检测联合血栓弹力图对预测血小板减少症预后的临床价值分析 [J]. 国际检验医学杂志 , 2021 , 42 ( 6 ): 747 - 749 .
荆晶 , 王文婷 , 常艳 , 等 . 临床凝血功能异常患者血栓弹力图与常规凝血检测的比较及相关性分析 [J]. 中国实验血液学杂志 , 2020 , 28 ( 2 ): 629 - 635 .
刘书方 , 余惠平 , 谢欢来 , 等 . 探索扶正解毒方对免疫性血小板减少症儿童患者血小板功能的影响 [J]. 环球中医药 , 2017 , 10 ( 10 ): 1178 - 1184 .
0
浏览量
3
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号